Loss of SMAD4 activity is a common characteristic of gastrointestinal tumors and is most frequently observed in CCA originating in the distal common bile duct, near the pancreas—where SMAD4 mutations are particularly prevalent [163]. This evidence concerns the gene SMAD4 and digestive system neoplasm.